LifeStance Health Group, Inc. $LFST Holdings Trimmed by Group One Trading LLC

Group One Trading LLC reduced its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 90.7% during the 1st quarter, Holdings Channel.com reports. The firm owned 5,008 shares of the company’s stock after selling 49,014 shares during the period. Group One Trading LLC’s holdings in LifeStance Health Group were worth $32,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of LFST. Larson Financial Group LLC boosted its position in shares of LifeStance Health Group by 19,952.6% in the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after buying an additional 3,791 shares during the period. KBC Group NV purchased a new position in shares of LifeStance Health Group during the first quarter valued at $29,000. Bayesian Capital Management LP acquired a new position in LifeStance Health Group during the second quarter valued at $52,000. PNC Financial Services Group Inc. raised its position in LifeStance Health Group by 615.3% during the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after buying an additional 7,987 shares during the period. Finally, Assetmark Inc. lifted its stake in LifeStance Health Group by 17.0% in the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after acquiring an additional 1,367 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $10.81 on Friday. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of 180.17 and a beta of 1.12. LifeStance Health Group, Inc. has a 1 year low of $3.74 and a 1 year high of $11.76. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.18. The business has a fifty day simple moving average of $9.27 and a 200 day simple moving average of $7.79.

LifeStance Health Group (NASDAQ:LFST) last issued its earnings results on Wednesday, May 6th. The company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.03. LifeStance Health Group had a return on equity of 1.56% and a net margin of 1.55%.The firm had revenue of $403.48 million for the quarter, compared to the consensus estimate of $387.46 million. The business’s revenue for the quarter was up 21.2% compared to the same quarter last year. As a group, sell-side analysts predict that LifeStance Health Group, Inc. will post 0.12 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Wall Street Zen upgraded LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. Zacks Research downgraded LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. The Goldman Sachs Group assumed coverage on shares of LifeStance Health Group in a research report on Friday, June 5th. They issued a “neutral” rating and a $9.00 price target for the company. JPMorgan Chase & Co. raised their price target on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Thursday, May 14th. Finally, BTIG Research raised their price target on shares of LifeStance Health Group from $11.00 to $12.00 and gave the stock a “buy” rating in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $11.12.

Insider Activity

In related news, Director Robert Bessler sold 894,337 shares of the stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $10.13, for a total value of $9,059,633.81. Following the transaction, the director owned 539,763 shares in the company, valued at approximately $5,467,799.19. This represents a 62.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Darren M. Black sold 5,899,661 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total value of $47,315,281.22. Following the completion of the transaction, the director owned 23,310,115 shares in the company, valued at $186,947,122.30. This represents a 20.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 7,687,394 shares of company stock worth $63,579,701 in the last three months. 3.50% of the stock is owned by insiders.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.